Improvement of Neurodegenerative Disease after Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report

• Κύριοι συγγραφείς: Young Kwon Koh (Συγγραφέας), Su Hyun Yoon (Συγγραφέας), Sung Han Kang (Συγγραφέας), Hyery Kim (Συγγραφέας), Ho Joon Im (Συγγραφέας), Pyeong Hwa Kim (Συγγραφέας), Ah Young Jung (Συγγραφέας), Kyung-Nam Koh (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: The Korean Society of Pediatric Hematology-Oncology, 2022-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder characterized by heterogenous lesions infiltrated with CD1a+/CD207+ cells. Although LCH has a relatively good prognosis, the prognosis for patients with LCH refractory to standard chemotherapy is poor. Neurodegenerative LCH (ND-LCH)...